Another reason to embrace quadruple medical therapy for heart failure: medications enabling tolerance of each other

Volume: 23, Issue: 9, Pages: 1525 - 1528
Published: Jul 29, 2021
Abstract
This article refers to ‘Effect of sacubitril/valsartan vs. enalapril on changes in heart failure therapies over time: the PARADIGM-HF trial’ by A.S. Bhatt et al., published in this issue on pages 1518–1524. To date, the care of heart failure (HF) with reduced ejection fraction (HFrEF) has accumulated multiple medications proven to improve patient survival: evidence-based beta-blocker, angiotensin-converting enzyme inhibitor (ACEI)/angiotensin II...
Paper Details
Title
Another reason to embrace quadruple medical therapy for heart failure: medications enabling tolerance of each other
Published Date
Jul 29, 2021
Volume
23
Issue
9
Pages
1525 - 1528
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.